Literature DB >> 3285983

Natural infection with an attaching and effacing Escherichia coli in a diarrheic puppy.

A Broes1, R Drolet, M Jacques, J M Fairbrother, W M Johnson.   

Abstract

Enteric infection with an attaching and effacing Escherichia coli was diagnosed in a puppy with protracted diarrhea. Extensive colonization of the small intestinal mucosa was observed by light and scanning electron microscopy and characteristic lesions of bacterial attachment of the brush border of the enterocytes were demonstrated by transmission electron microscopy. The E. coli strain isolated from the small intestine belonged to serotype O49:H10, did not produce any known E. coli enterotoxin or cytotoxin, was not invasive, and was negative for the known fimbrial colonization factors produced by animal and human enterotoxigenic E. coli. A positive immunoperoxidase reaction was obtained on the bacteria attached to the enterocytes with an anti-E. coli O49 antiserum.

Entities:  

Mesh:

Year:  1988        PMID: 3285983      PMCID: PMC1255441     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  10 in total

1.  BREED SUSCEPTIBILITY, PATHOGENICITY AND EPIDEMIOLOGY OF ENDEMIC COLIFORM ENTERITIS IN THE DOG.

Authors:  I W FOX; W G HOAG; J STROUT
Journal:  Lab Anim Care       Date:  1965-06

2.  [Not Available].

Authors:  B SERENY
Journal:  Acta Microbiol Acad Sci Hung       Date:  1957

3.  New fimbrial antigen F165 from Escherichia coli serogroup O115 strains isolated from piglets with diarrhea.

Authors:  J M Fairbrother; S Larivière; R Lallier
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

4.  Pathogenicity of attaching effacing enteropathogenic Escherichia coli isolated from diarrheic suckling and weanling rabbits for newborn rabbits.

Authors:  J E Peeters; G J Charlier; P H Halen
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

5.  Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves.

Authors:  R A Moxley; D H Francis
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Attaching and effacing bacteria in the intestines of calves and cats with diarrhea.

Authors:  A Pospischil; J G Mainil; G Baljer; H W Moon
Journal:  Vet Pathol       Date:  1987-07       Impact factor: 2.221

7.  An ultrastructural study of enteropathogenic Escherichia coli infection in human infants.

Authors:  R J Rothbaum; J C Partin; K Saalfield; A J McAdams
Journal:  Ultrastruct Pathol       Date:  1983-06       Impact factor: 1.094

8.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

9.  Virulence properties of enterotoxigenic Escherichia coli O8: KX105 strains isolated from diarrheic piglets.

Authors:  A Broes; J M Fairbrother; S Larivière; M Jacques; W M Johnson
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

  10 in total
  11 in total

1.  Interaction of enteropathogenic and Shiga toxin-producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.

Authors:  Francis Girard; Isabelle Batisson; Gad M Frankel; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Enteropathogenic Escherichia coli (EPEC) infection in association with acute gastroenteritis in 7 dogs from Saskatchewan.

Authors:  Astrid B Kjaergaard; Anthony P Carr; M Casey Gaunt
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

3.  Genotypic and phenotypic characterization of Escherichia coli isolates from dogs manifesting attaching and effacing lesions.

Authors:  M Beaudry; C Zhu; J M Fairbrother; J Harel
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Identification of a family of intimins common to Escherichia coli causing attaching-effacing lesions in rabbits, humans, and swine.

Authors:  T S Agin; M K Wolf
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

5.  Molecular evolution of typical enteropathogenic Escherichia coli: clonal analysis by multilocus sequence typing and virulence gene allelic profiling.

Authors:  David W Lacher; Hans Steinsland; T Eric Blank; Michael S Donnenberg; Thomas S Whittam
Journal:  J Bacteriol       Date:  2006-11-10       Impact factor: 3.490

6.  Interaction with pig ileal explants of Escherichia coli O45 isolates from swine with postweaning diarrhea.

Authors:  C Zhu; J Harel; M Jacques; J M Fairbrother
Journal:  Can J Vet Res       Date:  1995-04       Impact factor: 1.310

7.  Characterization of the novel factor paa involved in the early steps of the adhesion mechanism of attaching and effacing Escherichia coli.

Authors:  Isabelle Batisson; Marie-Pierre Guimond; Francis Girard; Hongyan An; Chengru Zhu; Eric Oswald; John M Fairbrother; Mario Jacques; Josée Harel
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Virulence properties and attaching-effacing activity of Escherichia coli O45 from swine postweaning diarrhea.

Authors:  C Zhu; J Harel; M Jacques; C Desautels; M S Donnenberg; M Beaudry; J M Fairbrother
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Attaching and effacing and enterotoxigenic Escherichia coli associated with enteric colibacillosis in the dog.

Authors:  R Drolet; J M Fairbrother; J Harel; P Hélie
Journal:  Can J Vet Res       Date:  1994-04       Impact factor: 1.310

10.  Experimental infection of newborn pigs with an attaching and effacing Escherichia coli O45:K"E65" strain.

Authors:  P Helie; M Morin; M Jacques; J M Fairbrother
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.